参考文献/References:
[1] QIN C, DONG Q, CUI L. Chinese guidelines for diagnosis and treatment of subarachnoid hemorrhage 2019 [J]. Chin J Neurol, 2019, 52 (12): 1006-1021. 秦 超，董 强，崔丽英. 中国蛛网膜下腔出血诊治指南2019[J]. 中华神经科杂志，2019，52（12）：1006-1021.
[2] LIU L, KAWAKITA F, FUJIMOTO M, et al. Role of periostin in early brain injury after subarachnoid hemorrhage in mice [J]. Stroke, 2017, 48(4): 1108-1111.
[3] KAWAKITA F, KANAMARU H, ASADA R, et al. Potential roles of matricellular proteins in stroke [J]. Exper Neurol, 2019, 322: 113057.
[4]LIU L, FUJIMOTO M, KAWAKITA F, et al. Anti-vascular endothelial growth factor treatment suppresses early brain injury after subarachnoid hemorrhage in mice [J]. Mol Neurobiol, 2016, 53(7): 4529-4538.
[5] LIU L, FUJIMOTO M, NAKANO F, et al. Deficiency of tenascin-C alleviates neuronal apoptosis and neuroinflammation after experimental subarachnoid hemorrhage in mice [J]. Mol Neurobiol, 2018, 55(11): 8346-8354.
[6] FU Z, ZHU G, LUO C, et al. Matricellular protein tenascin C: implications in glioma progression, gliomagenesis, and treatment [J]. Front Oncol, 2022, 12: 971462.
[7] OKADA T, SUZUKI H. The role of tenascin-C in tissue injury and repair after stroke [J]. Front Immunol, 2020, 11: 607587.
[8] BRISTOW J, TEE MK, GITELMAN SE, et al. Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B [J]. J Cell Biol, 1993, 122(1): 265-278.
[9] CHIOVARO F, CHIQUET-EHRISMANN R, CHIQUET M. Transcriptional regulation of tenascin genes [J]. Cell Adh Migr, 2015, 9 (1-2): 34-47.
[10] WANG Y, WANG G, LIU H. Tenascin-C: a key regulator in angiogenesis during wound healing [J]. Biomolecules, 2022, 12(11): 1689.
[11] HASEGAWA M, YOSHIDA T, SUDO A. Tenascin-C in osteoarthritis and rheumatoid arthritis [J]. Front Immunol, 2020, 11: 577015.
[12] TUCI M, STAMENKOVI V, ANDJUS P. The extracellular matrix glycoprotein tenascin C and adult neurogenesis [J]. Front Cell Devel Biol, 2021, 9: 674199.
[13] MIDWOOD KS, OREND G. The role of tenascin-C in tissue injury and tumorigenesis [J]. J Cell Commun Signal, 2009, 3(3-4): 287-310.
[14] SUZUKI H, KAWAKITA F. Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective [J]. Neural Regen Res, 2016, 11(2): 230-231.
[15] SHIBA M, SUZUKI H. Lessons from tenascin-C knockout mice and potential clinical application to subarachnoid hemorrhage [J]. Neural Regen Res, 2019, 14(2): 262-264.
[16] SUZUKI H, KINOSHITA N, IMANAKA-YOSHIDA K, et al. Cerebrospinal fluid tenascin-C increases preceding the development of chronic shunt-dependent hydrocephalus after subarachnoid hemorrhage [J]. Stroke, 2008, 39(5): 1610-1612.
[17] SUZUKI H, KANAMARU K, SHIBA M, et al. Cerebrospinal fluid tenascin-C in cerebral vasospasm after aneurysmal subarachnoid hemorrhage [J]. J Neurosurg Anesthesiol, 2011, 23(4): 310-317.
[18] SUZUKI H, FUJIMOTO M, KAWAKITA F, et al. Toll-like receptor 4 and tenascin-C signaling in cerebral vasospasm and brain injuries after subarachnoid hemorrhage [J]. Acta Neurochir Suppl, 2020, 127: 91-96.
[19] SUZUKI H, FUJIMOTO M, KAWAKITA F, et al. Tenascin-C in brain injuries and edema after subarachnoid hemorrhage: findings from basic and clinical studies [J]. J Neurosci Res, 2020, 98(1): 42-56.
[20] BUCHANAN MM, HUTCHINSON M, WATKINS LR, et al. Tolllike receptor 4 in CNS pathologies [J]. J Neurochem, 2010, 114(1): 13-27.
[21] OKADA T, SUZUKI H. Toll-like receptor 4 as a possible therapeutic target for delayed brain injuries after aneurysmal subarachnoid hemorrhage [J]. Neural Regen Res, 2017, 12(2): 193-196.
[22] NAG S, MANIAS JL, STEWART DJ. Pathology and new players in the pathogenesis of brain edema [J]. Acta Neuropathol, 2009, 118 (2): 197-217.
[23] ILUNGA K, NISHIURA R, INADA H, et al. Co-stimulation of human breast cancer cells with transforming growth factor-beta and tenascin-C enhances matrix metalloproteinase-9 expression and cancer cell invasion [J]. Int J Exp Pathol, 2004, 85(6): 373-379.
[24] KURIYAMA N, DUARTE S, HAMADA T, et al. Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury [J]. Hepatol (Baltimore, Md), 2011, 54(6): 2125-2136.
[25] KALEMBEYI I, INADA H, NISHIURA R, et al. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1 [J]. Int J Cancer, 2003, 105(1): 53-60.
[26] FUJIMOTO M, SHIBA M, KAWAKITA F, et al. Deficiency of tenascin-C and attenuation of blood-brain barrier disruption following experimental subarachnoid hemorrhage in mice [J]. J Neurosurg, 2016, 124(6): 1693-1702.
[27] NISHIKAWA H, SUZUKI H. Possible role of inflammation and galectin-3 in brain injury after subarachnoid hemorrhage [J]. Brain Sci, 2018, 8(2): 30.
[28] HASEGAWA Y, SUZUKI H, ALTAY O, et al. Preservation of tropomyosin-related kinase B (TrkB) signaling by sodium orthovanadate attenuates early brain injury after subarachnoid hemorrhage in rats [J]. Stroke, 2011, 42(2): 477-483.
[29] SHIBA M, FUJIMOTO M, IMANAKA-YOSHIDA K, et al. Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats [J]. Transl Stroke Res, 2014, 5(2): 238-247.
[30] GOLLEDGE J, CLANCY P, MAGUIRE J, et al. The role of tenascin C in cardiovascular disease [J]. Cardiovasc Res, 2011, 92(1): 19-28.
[31] SUZUKI H, NAKATSUKA Y, YASUDA R, et al. Dose-dependent inhibitory effects of cilostazol on delayed cerebral infarction after aneurysmal subarachnoid hemorrhage [J]. Transl Stroke Res, 2019, 10(4): 381-388.
[32] FUJINAGA K, ONODA K, YAMAMOTO K, et al. Locally applied cilostazol suppresses neointimal hyperplasia by inhibiting tenascinC synthesis and smooth muscle cell proliferation in free artery grafts [J]. J Thorac Cardiovasc Surg, 2004, 128(3): 357-363.
[33] NAKATSUKA Y, KAWAKITA F, YASUDA R, et al. Preventive effects of cilostazol against the development of shunt-dependent hydrocephalus after subarachnoid hemorrhage [J]. J Neurosurg, 2017, 127(2): 319-326.
[34] SHARIFI BG, LAFLEUR DW, PIROLA CJ, et al. Angiotensin Ⅱ regulates tenascin gene expression in vascular smooth muscle cells [J]. J Biol Chem, 1992, 267(33): 23910-23915.
[35] YAMAMOTO K, DANG QN, KENNEDY SP, et al. Induction of tenascin-C in cardiac myocytes by mechanical deformation: role of reactive oxygen species [J]. J Biol Chem, 1999, 274(31): 21840-21846.
相似文献/References:
[1]旷仁钊 唐晓平 漆 建 苟章洋.丹红注射液对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(11):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
KUANG Ren-zhao,TANG Xiao-ping,QI Jian,et al.Effects of Danhong on cerebral vasospasm after subara- chnoid hemorrhage in rats[J].,2015,(10):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
[2]周路桥 罗富强 彭 虎 邱成元 刘 苏 蒋国辉 田 强 罗荣武.皮瓣塌陷综合征患者颅骨修补术后继发蛛网膜下腔出血1例[J].中国临床神经外科杂志,2015,(11):704.[doi:10.13798/j.issn.1009-153X.2015.11.022]
[3]李朝晖 王玉贵 张孟超 综述 赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的
临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[4]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[5]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(10):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[6]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[7]水 涛 郭再玉 综述 马廉亭 审校.蛛网膜下腔出血后脑血管痉挛的亚低温治疗进展[J].中国临床神经外科杂志,2016,(03):185.[doi:10.13798/j.issn.1009-153X.2016.03.021]
[8]赵建伍 于耀宇 余天垒 李延良 唐 铸 桂 铮 周 欣 姬文婕.黄芪甲苷对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(06):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
ZHAO Jian-wu,YU Yao-yu,YU Tian-lei,et al.Effects of Astragaloside Ⅳ on delayed cerebral vasospasm after subarachnoid hemorrhage[J].,2015,(10):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
[9]祝 源 李 俊 陈 刚 向伟楚 李国栋 赵曰圆 李欢欢 汤 伟 金二亮 马廉亭.两次DSA阴性的颅内破裂动脉瘤1例报道并文献复习[J].中国临床神经外科杂志,2015,(09):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
ZHU Yuan,LI Jun,CHEN Gang,et al.Both negative DSA findings in 1 patient with ruptured intracranial aneurysm (case report and review of literature)[J].,2015,(10):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
[10]旷仁钊 综述 唐晓平 审校.蛛网膜下腔出血后脑血管痉挛药物治疗的研究进展[J].中国临床神经外科杂志,2015,(09):572.[doi:10.13798/j.issn.1009-153X.2015.09.024]
[11]刘彬冰,史怀璋.蛛网膜下腔出血后炎症反应的研究进展[J].中国临床神经外科杂志,2018,(09):636.[doi:10.13798/j.issn.1009-153X.2018.09.023]
[12]方 翌 综述 武永康 审校.蛛网膜下腔出血后铁代谢和神经细胞自噬的关系[J].中国临床神经外科杂志,2018,(11):734.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[13]杨新宇 韩雨薇 陈立刚 李佳朔 潘鹏宇 梁国标.C3G通过PKA/CREB信号通路减轻成年小鼠SAH后早期脑损伤[J].中国临床神经外科杂志,2022,27(04):278.[doi:10.13798/j.issn.1009-153X.2022.04.011]
YANG Xin-yu,HAN Yu-wei,CHEN Li-gang,et al.Cyanidin-3-O-glucoside attenuates early brain injury after subarachnoid hemorrhage in adult mice through PKA/CREB signaling pathway[J].,2022,27(10):278.[doi:10.13798/j.issn.1009-153X.2022.04.011]